在新生儿肺高血压中吸入氧化
Michael W Cookson1, John P Kinsella1
1Department of Pediatrics, Section of Neonatology, University of Colorado, Anschutz School of Medicine and Children's Hospital Colorado, Aurora, CO 80045, USA; Department of Pediatrics, Pediatric Heart Lung Center, University of Colorado Anschutz School of Medicine and Children's Hospital Colorado, Aurora, CO, USA.
Clinics in perinatology
|February 7, 2024
概括
吸入的氧化 (iNO) 是治疗新生儿持续性肺高血压 (PPHN) 的唯一经批准的血管扩张剂. 它在肺高血压新生儿的向使用是安全和有益的.
科学领域:
- 新生儿医学 新生儿医学
- 肺高血压研究 肺高血压研究
- 药理学 药理学是指药理学的学科.
背景情况:
- 新生儿持续性肺高血压 (PPHN) 是新生儿的一个危急病.
- 吸入的氧化 (iNO) 在1990年代的关键试验后成为一个关键的治疗剂.
- 1999年,iNO获得了FDA的批准,用于治疗PPHN.
研究的目的:
- 审查吸入氧化 (iNO) 的历史发展和临床应用.
- 讨论新生儿肺高血压 (PH) 的临床特征.
- 评估iNO在新生儿PH管理中的安全性和益处.
主要方法:
- 对iNO的关键试验和临床研究的文献综述.
- 对iNO的批准和使用的历史数据的分析.
- 对新生儿PH和iNO的作用的当前理解的综合.
主要成果:
- 吸入的氧化是FDA批准的唯一用于PPHN的肺血管扩张剂.
- 使用iNO进行选择性肺血管扩张在治疗PPHN的终期和近期新生儿中是安全的.
- 针对性地使用iNO可以在患有肺高血压的较不成熟新生儿中有益.
结论:
- 吸入的氧化仍然是PPHN的基石治疗.
- 在新生儿肺高血压中使用iNO需要仔细考虑妊娠年龄和特定的临床背景.
- 继续研究和了解iNO的机制和应用是很重要的.
相关概念视频
Nitric Oxide Signaling Pathway
5.0K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.0K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
216
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
216
Pulmonary Cycle: Exhalation
1.6K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.6K
Pulmonary Hypertension: Classification and Pathogenesis
180
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
180


